• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis.支气管扩张症中铜绿假单胞菌慢性定植的预测因素。
Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2299-2304. doi: 10.1007/s10096-019-03675-z. Epub 2019 Aug 31.
2
Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.严重慢性阻塞性肺疾病中的铜绿假单胞菌分离株:特征和危险因素。
BMC Pulm Med. 2014 Jun 26;14:103. doi: 10.1186/1471-2466-14-103.
3
Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.非囊性纤维化支气管扩张症:铜绿假单胞菌持续存在与耐药性的纵向回顾性观察队列研究
Respir Med. 2015 Jun;109(6):716-26. doi: 10.1016/j.rmed.2014.07.021. Epub 2014 Aug 29.
4
Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection.支气管扩张症合并慢性铜绿假单胞菌感染患者吸入多黏菌素的情况。
Am J Respir Crit Care Med. 2014 Apr 15;189(8):975-82. doi: 10.1164/rccm.201312-2208OC.
5
The independent contribution of infection to long-term clinical outcomes in bronchiectasis.感染对支气管扩张长期临床结局的独立影响。
Eur Respir J. 2018 Jan 31;51(2). doi: 10.1183/13993003.01953-2017. Print 2018 Feb.
6
Risk factors for Pseudomonas aeruginosa colonization in non-cystic fibrosis bronchiectasis and clinical implications.非囊性纤维化支气管扩张症中铜绿假单胞菌定植的危险因素及其临床意义。
Respir Res. 2021 Apr 28;22(1):132. doi: 10.1186/s12931-021-01729-5.
7
Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.黏液化铜绿假单胞菌中存在 pldA 和 exoU 与非囊性纤维化支气管扩张症患者加重的高风险相关。
Clin Microbiol Infect. 2019 May;25(5):601-606. doi: 10.1016/j.cmi.2018.07.008. Epub 2018 Jul 21.
8
The contribution of infection to clinical outcomes in bronchiectasis: a prospective cohort study.感染对支气管扩张临床结局的影响:一项前瞻性队列研究。
Ann Med. 2021 Dec;53(1):459-469. doi: 10.1080/07853890.2021.1900594.
9
Exacerbations and Pseudomonas aeruginosa colonization are associated with altered lung structure and function in primary ciliary dyskinesia.在原发性纤毛运动障碍中,加重期和铜绿假单胞菌定植与肺结构和功能的改变有关。
BMC Pediatr. 2020 Apr 13;20(1):158. doi: 10.1186/s12887-020-02062-4.
10
Lung function in bronchiectasis: the influence of Pseudomonas aeruginosa.支气管扩张症中的肺功能:铜绿假单胞菌的影响
Eur Respir J. 1996 Aug;9(8):1601-4. doi: 10.1183/09031936.96.09081601.

引用本文的文献

1
Cost-effectiveness analysis of two inhaled antibiotics for stable Bronchiectasis with Pseudomonas aeruginosa infections in China.中国两种吸入性抗生素治疗铜绿假单胞菌感染的稳定期支气管扩张症的成本效益分析
PLoS One. 2025 Jun 18;20(6):e0324254. doi: 10.1371/journal.pone.0324254. eCollection 2025.
2
Mortality and exacerbations in bronchiectasis patients with carbapenem-resistant Pseudomonas aeruginosa isolation: a long-term retrospective cohort study.分离出耐碳青霉烯类铜绿假单胞菌的支气管扩张症患者的死亡率和病情加重情况:一项长期回顾性队列研究
Ann Clin Microbiol Antimicrob. 2025 May 6;24(1):30. doi: 10.1186/s12941-025-00798-4.
3
Pulmonary microbiology and microbiota in adults with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis.非囊性纤维化支气管扩张症成人患者的肺部微生物学与微生物群:一项系统评价和荟萃分析
Respir Res. 2025 Feb 28;26(1):77. doi: 10.1186/s12931-025-03140-w.
4
Multi-drug resistant Pseudomonas aeruginosa isolation is an independent risk factor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a retrospective cohort study.多重耐药铜绿假单胞菌分离是特发性支气管扩张症患者支气管动脉栓塞后复发性咯血的独立危险因素:一项回顾性队列研究。
Respir Res. 2024 Oct 26;25(1):385. doi: 10.1186/s12931-024-03019-2.
5
Epidemiology of bronchiectasis.支气管扩张症的流行病学。
Eur Respir Rev. 2024 Oct 9;33(174). doi: 10.1183/16000617.0091-2024. Print 2024 Oct.
6
Clinical Impacts of Isolation in Patients with Bronchiectasis: Findings from KMBARC Registry.支气管扩张症患者隔离的临床影响:来自KMBARC注册研究的结果
J Clin Med. 2024 Aug 24;13(17):5011. doi: 10.3390/jcm13175011.
7
Infection and the microbiome in bronchiectasis.支气管扩张症中的感染和微生物组。
Eur Respir Rev. 2024 Jul 3;33(173). doi: 10.1183/16000617.0038-2024. Print 2024 Jul.
8
Pseudomonas aeruginosa in tracheal aspirate: Colonization, infection, and recurrence.气管吸出物中的铜绿假单胞菌:定植、感染和复发。
Clin Respir J. 2023 May;17(5):439-446. doi: 10.1111/crj.13612. Epub 2023 Apr 27.
9
Prevalence and Virulence of Commensal Pseudomonas Aeruginosa Isolates from Healthy Individuals in Southern Vietnam (2018-2020).越南南部健康个体共生铜绿假单胞菌分离株的流行率和毒力(2018 - 2020年)
Biomedicines. 2022 Dec 26;11(1):54. doi: 10.3390/biomedicines11010054.
10
Application of High-Throughput Sequencing Technology in the Pathogen Identification of Diverse Infectious Diseases in Nephrology Departments.高通量测序技术在肾内科多种感染性疾病病原体鉴定中的应用
Diagnostics (Basel). 2022 Sep 1;12(9):2128. doi: 10.3390/diagnostics12092128.

本文引用的文献

1
The independent contribution of infection to long-term clinical outcomes in bronchiectasis.感染对支气管扩张长期临床结局的独立影响。
Eur Respir J. 2018 Jan 31;51(2). doi: 10.1183/13993003.01953-2017. Print 2018 Feb.
2
Clinical impact of Pseudomonas aeruginosa colonization in patients with Primary Ciliary Dyskinesia.原发性纤毛运动障碍患者铜绿假单胞菌定植的临床影响。
Respir Med. 2017 Oct;131:241-246. doi: 10.1016/j.rmed.2017.08.028. Epub 2017 Sep 1.
3
A longitudinal study characterising a large adult primary ciliary dyskinesia population.一项大型成人原发性纤毛运动障碍人群的纵向研究。
Eur Respir J. 2016 Aug;48(2):441-50. doi: 10.1183/13993003.00209-2016. Epub 2016 Jun 10.
4
A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis.铜绿假单胞菌定植对成人支气管扩张症预后影响的综合分析。
Ann Am Thorac Soc. 2015 Nov;12(11):1602-11. doi: 10.1513/AnnalsATS.201506-333OC.
5
Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance.非囊性纤维化支气管扩张症:铜绿假单胞菌持续存在与耐药性的纵向回顾性观察队列研究
Respir Med. 2015 Jun;109(6):716-26. doi: 10.1016/j.rmed.2014.07.021. Epub 2014 Aug 29.
6
Mortality in non-cystic fibrosis bronchiectasis: a prospective cohort analysis.非囊性纤维化支气管扩张症的死亡率:一项前瞻性队列分析。
Respir Med. 2014 Feb;108(2):287-96. doi: 10.1016/j.rmed.2013.12.015. Epub 2014 Jan 8.
7
The bronchiectasis severity index. An international derivation and validation study.支气管扩张严重指数。一项国际推导和验证研究。
Am J Respir Crit Care Med. 2014 Mar 1;189(5):576-85. doi: 10.1164/rccm.201309-1575OC.
8
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score.多维方法治疗非囊性纤维化性支气管扩张症:FACED 评分。
Eur Respir J. 2014 May;43(5):1357-67. doi: 10.1183/09031936.00026313. Epub 2013 Nov 14.
9
British Thoracic Society guideline for non-CF bronchiectasis.英国胸科学会非囊性纤维化支气管扩张指南。
Thorax. 2010 Jul;65(7):577. doi: 10.1136/thx.2010.142778.
10
Mortality in bronchiectasis: a long-term study assessing the factors influencing survival.支气管扩张症的死亡率:一项评估影响生存因素的长期研究。
Eur Respir J. 2009 Oct;34(4):843-9. doi: 10.1183/09031936.00003709. Epub 2009 Apr 8.

支气管扩张症中铜绿假单胞菌慢性定植的预测因素。

Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis.

机构信息

Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Eur J Clin Microbiol Infect Dis. 2019 Dec;38(12):2299-2304. doi: 10.1007/s10096-019-03675-z. Epub 2019 Aug 31.

DOI:10.1007/s10096-019-03675-z
PMID:31471703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6858402/
Abstract

About 25% of the patients with bronchiectasis are likely to develop a chronic colonization with Pseudomonas aeruginosa. A better understanding of predictors of acquiring Pseudomonas within the patient population may facilitate future focused research. The aim of this retrospective observational study was to investigate predicting factors for P. aeruginosa colonization in patients with bronchiectasis. This was a single-center retrospective cohort study using a bronchiectasis database which consisted of 211 patients with bronchiectasis. Data were collected for demographic details, etiology, spirometry, microbiology data, maintenance medication use, exacerbation frequency, hospital admission rate, and FACED and Bronchiectasis Severity Index (BSI) score. Two hundred eleven patients were identified from our bronchiectasis database. Overall, 25% of the patients (n = 53) had a chronic colonization with P. aeruginosa. Seventeen patients (8%) died in a 5-year follow-up period of whom 7 (41%) had a chronic P. aeruginosa colonization (p > 0.05). After multiple regression analysis, P. aeruginosa-positive patients were significantly associated with an older age (> 55 years) (p = 0.004), the use of hypertonic saline (0.042), and inhalation antibiotics (< 0.001). Furthermore, the presence of PCD (p < 0.001) and post-infectious etiology (p < 0.001) as underlying causes were significantly associated with P. aeruginosa colonization. We observed that independent predictors for P. aeruginosa colonization were age > 55 years, hypertonic saline, and PCD, and post-infectious etiology as underlying causes of bronchiectasis. Since prevention of P. aeruginosa colonization is an important aim in the treatment of bronchiectasis, more attention could be directed to these groups at risk for Pseudomonas colonization.

摘要

约 25%的支气管扩张症患者可能会出现铜绿假单胞菌的慢性定植。更好地了解患者人群中获得铜绿假单胞菌的预测因素,可能有助于未来的针对性研究。本回顾性观察性研究旨在调查支气管扩张症患者铜绿假单胞菌定植的预测因素。这是一项使用支气管扩张症数据库的单中心回顾性队列研究,该数据库包含 211 例支气管扩张症患者。收集人口统计学细节、病因、肺量测定、微生物学数据、维持性药物使用、加重频率、住院率以及 FACED 和支气管扩张严重指数(BSI)评分的数据。从我们的支气管扩张症数据库中确定了 211 例患者。总体而言,25%的患者(n=53)存在铜绿假单胞菌慢性定植。在 5 年的随访期间,有 17 例患者(8%)死亡,其中 7 例(41%)存在慢性铜绿假单胞菌定植(p>0.05)。经过多变量回归分析,铜绿假单胞菌阳性患者与年龄较大(>55 岁)(p=0.004)、使用高渗盐水(0.042)和吸入性抗生素(<0.001)显著相关。此外,存在原发性纤毛运动障碍(PCD)(p<0.001)和感染后病因(p<0.001)作为潜在病因与铜绿假单胞菌定植显著相关。我们观察到,铜绿假单胞菌定植的独立预测因素是年龄>55 岁、高渗盐水和 PCD,以及感染后病因是支气管扩张症的潜在病因。由于预防铜绿假单胞菌定植是支气管扩张症治疗的一个重要目标,因此应该更加关注这些有铜绿假单胞菌定植风险的群体。